Dr Jarred Younger, a prominent researcher in neuroinflammation and chronic pain, has publicly stated that semaglutide does reduce chronic pain via these three pathways, but also acknowledged that all the semaglutide and microglia studies I know of are in animal models theres still another step that needs to be taken. That caveat matters enormously, and its one well come back to
Importantly, the fusion proteins that remained bound to the immobilized receptor at the end of the dissociation phase, rapidly dissociated upon injection of a pH 7.4 buffer during the regeneration phase (Supplementary Fig
It hits three receptors at once: GLP-1 (cuts appetite, slows stomach), GIP (improves insulin signaling), and glucagon (raises energy expenditure and fat mobilization)
Your physician must be able to explain why the treatment itself is the best option available, how it will improve the condition, and back these claims with clinical evidentiary support